Jiang et al. showed that miR-363 can target the expression of E2F3 and inhibit the proliferation and invasion of HepG2 cells 30, but whether miR-363 can play its role by inhibiting the expression of E2F3 in CRC cells has not been reported, and further studies are needed. The gene discussed is E2F3; the disease is colorectal carcinoma.